Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
- A4123 KW 2449Target: Aurora Kinases|FLT3|Bcr-AblSummary: Multikinase inhibitor
- A2168 Dovitinib (TKI-258, CHIR-258)2 CitationTarget: FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Multitargeted RTK inhibitor
- A5793 Quizartinib (AC220)Target: FLT3Summary: FLT3 inhibitor,potent and selective
- A8307 Crenolanib (CP-868596)1 CitationTarget: FLT3|PDGFRSummary: PDGFR-β inhibitor,potent and selective
- A8476 MK-2461Target: FLT3|PDGFR|MET|RonSummary: C-Met (WT/mutants) inhibitor
- B1404 DCC-2036 (Rebastinib)Target: FLT3|Bcr-Abl|Tie-2|KDRSummary: Bcr-Abl inhibitor
- A8889 G-749Target: Aurora Kinases|FLT3|c-RETSummary: FLT3 inhibitor
- B8016 UNC20251 CitationTarget: MER|FLT3Summary: orally bioavailable dual MER/FLT3 inhibitor
- B5832 Altiratinib1 CitationTarget: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2Summary: c-MET/TIE-2/VEGFR inhibitor
- B5835 AZD2932Target: FLT3|VEGFR|PDGFR|c-KitSummary: inhibitor of VEGFR-2, PDGFRβ, Flt-3, and c-Kit